Nureca Share Price Target 2026 Analyst Forecast Bull and Bear Case
- July 1, 2026
- Posted by: Kunal Singla
- Category: News
Nureca CMP Rs 240. 52W High Rs 344 | Low Rs 200. Mcap Rs 223 Cr. 12M Target Rs 300. PE: 107.34.
The Nureca share price target, currently trading near its 52-week low of Rs 200, stands at Rs 300 for 2026, implying approximately 25% upside from the current market price of Rs 240. The stock trades at a price-to-earnings ratio of 107.34x, pricing in robust earnings growth expectations, with a market capitalisation of Rs 223 Cr. Investors tracking the healthcare devices segment are closely watching Nureca as an emerging opportunity given its 52-week range of Rs 200 to Rs 344. This analysis covers the bull case, bear case, and key catalysts that will define the Nureca share price target trajectory through 2026.
Click Here – Get Free Investment Predictions
Nureca Company Overview and Key Metrics
| Nureca | Details |
|---|---|
| NSE Symbol | NURECA |
| Sector | Healthcare Devices |
| CMP (Rs) | 240 |
| 52W High (Rs) | 344 |
| 52W Low (Rs) | 200 |
| Market Cap (Rs Cr) | 223 Cr |
| P/E Ratio | 107.34 |
| 12M Target (Rs) | 300 |
| Bull Case (Rs) | 345 |
| Bear Case (Rs) | 240 |
Nureca is a healthcare devices company listed on the National Stock Exchange (NSE: NURECA). With a market capitalisation of Rs 223 Cr, the company occupies a defined position in the Indian healthcare devices landscape. The stock has traded in a wide range over the past 12 months, touching a high of Rs 344 and a low of Rs 200, before arriving at its current level of Rs 240. Uniresearch analysts project a 12-month Nureca share price target of Rs 300, with a bull case of Rs 345 and a bear case of Rs 240.
Why Is the Nureca share price target Set at Rs 300 for 2026
FY27 Earnings Delivery and Revenue Acceleration
The Nureca share price target of Rs 300 is anchored in expectations of FY27 earnings delivery. At a P/E of 107.34x on trailing earnings, the stock is priced for consistent execution. Consistent revenue growth and margin improvement in coming quarters can re-rate the stock towards the Rs 300 target.
Strong Domestic Consumption and Growing Middle Class
India’s consumption story remains intact with GDP growth projected at 6.5-7% in FY27. A rising middle class with increasing discretionary spending is expanding the addressable market for companies across most sectors.
Favourable Policy Environment and Make in India Push
Government initiatives promoting domestic manufacturing through PLI schemes, import substitution, and ease of doing business reforms are structurally improving the operating environment for Indian companies.
RBI Rate Cut Cycle and Lower Cost of Capital
The Reserve Bank of India has shifted to an accommodative monetary policy stance, with rate cuts reducing borrowing costs across the economy. For Nureca, lower interest rates translate to reduced finance costs and potentially higher consumer demand in its end markets, creating a favourable backdrop for the Nureca share price target to materialise by year-end.
Union Budget 2026 and Policy Tailwinds
The Union Budget 2026-27 has maintained strong capex allocation of Rs 11 lakh crore for infrastructure, directly benefiting sectors including healthcare devices. Tax rationalisation and sector-specific policy support create a constructive policy environment that supports the Nureca share price target thesis through improved demand visibility.
Nureca Share Price Target Short Term, 12 Month and Long Term
Short Term Nureca Share Price Target: 3 to 6 Months
In the near term, the Nureca share price target for the next 3 to 6 months is pegged at Rs 260, contingent on Q1 FY27 earnings meeting expectations and sustained buying interest in the healthcare devices segment. Technically, the stock needs to hold the Rs 210-220 zone for this short-term target to remain valid.
12 Month Nureca Share Price Target 2026
Our 12-month Nureca share price target is Rs 300. This target is based on the Uniresearch fundamental estimate, which factors in FY27 revenue growth, margin normalisation, and sector re-rating potential. The Rs 300 level represents approximately 25% upside from the current price of Rs 240.
Long Term Nureca Share Price Target: FY27 to FY28
Over a 2 to 3 year horizon, the long-term Nureca share price target is estimated between Rs 345 and Rs 405, assuming continued compounding in earnings, potential capacity expansions, and improved market positioning. Investors with a multi-year holding perspective may find the current CMP of Rs 240 an attractive accumulation level.
Bull Case and Bear Case for Nureca Share Price Target
Bull Case: Rs 345
In the bull case scenario, Nureca delivers above-estimate earnings growth driven by strong demand, margin expansion, and new business wins. If these catalysts materialise simultaneously, the Nureca share price target could reach Rs 345, implying approximately 44% upside from the current market price.
Bear Case: Rs 240
The bear case of Rs 240 assumes earnings disappointment, sector-level de-rating, or broader market selloff driven by FII outflows. In this scenario, Nureca could re-test support levels closer to its 52-week low of Rs 200, representing a downside risk investors should monitor.
| Scenario | Target Price (Rs) | Upside/Downside from CMP | Key Assumption |
|---|---|---|---|
| Bull Case | 345 | 44% | Strong earnings growth, sector re-rating |
| Base Case | 300 | 25% | Steady earnings, margin improvement |
| Bear Case | 240 | 0% | Earnings miss, macro headwinds |
Key Risks to the Nureca Share Price Target 2026
Macro Headwind from Global Slowdown and US Tariff Policy
A sharper-than-expected global slowdown or escalation in US-China trade tensions could dampen demand across sectors. Nureca faces indirect risk if its customers or supply chain partners are impacted by slower global growth, as this could translate to lower order volumes or pricing pressure.
Valuation Risk and Earnings Miss Scenario
If Nureca reports quarterly earnings below analyst estimates or provides weak forward guidance, the stock could see significant de-rating. Elevated valuations in some segments leave limited margin for error, making execution risk a critical near-term concern.
Competitive Pressure in the Healthcare Devices Segment
The healthcare devices space in India is increasingly competitive with both domestic players and global companies vying for market share. Price competition, product commoditisation, or loss of key client contracts could pressure Nureca’s revenue trajectory.
FII Selling and Broader Market Volatility
Foreign Institutional Investor selling in Indian equities has historically led to broad-based price corrections even in fundamentally sound companies. Nureca’s share price could face near-term pressure if FII sentiment turns risk-off due to global monetary policy changes.
How to Invest in Nureca Stock
Step 1: Research and Fundamental Analysis. Before investing, thoroughly review Nureca’s quarterly results, annual report, and management commentary. Focus on revenue growth trajectory, operating margin trends, and debt levels to assess whether the Nureca share price target of Rs 300 is achievable.
Step 2: Use Stock Screeners for Live Data.
Check Nureca Live Data on Univest Screener
Monitor key metrics including P/E, return on equity, and promoter holding changes. These ratios can confirm or challenge the Nureca share price target thesis in real time.
Step 3: Define Your Entry Zone. The current CMP of Rs 240 is within the identified accumulation zone based on the 52-week low of Rs 200 and the Uniresearch target of Rs 300. Consider entering in tranches to average your cost over market fluctuations.
Step 4: Set Stop Loss and Risk Management Levels. Always define a stop-loss level before investing. A prudent stop-loss for Nureca based on the current technical setup would be in the Rs 211 to Rs 221 range. Never risk more than 2-5% of your portfolio in any single position.
Step 5: Open a Zero-Brokerage Demat Account. To invest in Nureca at zero brokerage, open your demat account with Univest, which combines SEBI-registered research with integrated trading. This allows you to act on the Nureca share price target analysis without incurring unnecessary transaction costs.
Download the Univest iOS App or Univest Android App to track Nureca live price and get daily stock recommendations.
Conclusion
The Nureca share price target for 2026 is Rs 300, with a bull case of Rs 345 and a bear case of Rs 240, based on Uniresearch estimates as of 29 June 2026. At a CMP of Rs 240 with a 52-week range of Rs 200 to Rs 344, Nureca presents a risk-reward opportunity that warrants monitoring. Investors should review Q1 FY27 results, track management commentary on guidance, and consult a SEBI-registered advisor before making investment decisions. The Nureca share price target outlined here is for educational purposes only.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Nureca Share Price Target 2026
What is the Nureca share price target for 2026?
Ans. The Nureca share price target for 2026, as per Uniresearch estimate, is Rs 300. This implies approximately 25% upside from the current market price of Rs 240.
Is Nureca a good stock to buy right now?
Ans. Whether Nureca is a good buy depends on your investment horizon, risk appetite, and portfolio allocation. The Uniresearch Nureca share price target of Rs 300 implies meaningful upside, but investors must assess company fundamentals and market conditions before investing.
What is Nureca’s 52-week high and low?
Ans. Nureca’s 52-week high is Rs 344 and the 52-week low is Rs 200, as of 29 June 2026. The current price of Rs 240 represents a 20% gain from the 52-week low.
What is the market cap of Nureca?
Ans. The market capitalisation of Nureca is approximately Rs 223 Cr, as of 29 June 2026.
What are the key risks to the Nureca share price target?
Ans. Key risks to the Nureca share price target of Rs 300 include earnings disappointment, global macro headwinds, FII selling pressure, and competitive intensity in the healthcare devices sector. Any of these factors could delay or reduce the target realisation.
What is the bull case target for Nureca in 2026?
Ans. In the bull case scenario, the Nureca share price target could reach Rs 345, implying approximately 44% upside from the current level. This assumes stronger-than-expected earnings growth and sector re-rating.
Where can I track Nureca share price live?
Ans. You can track Nureca (NSE: NURECA) live price, charts, and fundamental data on the Univest app or screener. The Univest platform provides real-time price data, analyst research, and portfolio tracking in one place.
How do I invest in Nureca stock?
Ans. To invest in Nureca, open a demat account with a SEBI-registered broker like Univest, which offers zero brokerage and integrated research. Search for the ticker NURECA on NSE, review fundamentals using the Univest Screener, and invest based on your financial goals and risk profile.
